Professor Nancy Ip discusses her groundbreaking neuroscience research, focusing on neurotrophic factors and innovative ...
Longer-term, Eisai and Biogen are hoping for further evidence to support Leqembi from the phase 3 AHEAD 3-45 trial, which ...
News Medical on MSN5d
Traditional Chinese herb shows promise against Alzheimer’s and Parkinson’sZizyphi spinosi semen demonstrates neuroprotective effects, improving cognitive function and reducing amyloid and tau pathology in models of aging and dementia.
Hosted on MSN3h
Ozempic and Viagra, among the more than 80 drugs expected to work against Alzheimer's in the coming years"There probably won't be a single magic solution for Alzheimer's disease. In the case of cancer and HIV ... For now, the ...
US pharmaceutical company Eli Lilly brings Memory Cafe to its booth at the ongoing 7th CIIE in collaboration with the ...
StringersHub on MSN2d
China: Robots, AI products widely applied to life, production scenarios in ChinaChina - Robots, AI products widely applied to life, production scenarios in China (Voice_over) Highly developed products like ...
Discover how traditional Chinese medicine is unlocking potential breakthroughs to dementia prevention and cognitive health.
The Canadian Press on MSN12d
Alzheimer Society supports advance MAID requests, but also good dementia careThe Alzheimer Society says people with dementia should have the right to request medical assistance in dying in advance — but ...
According to a new study, Mahjong, a game that is popular in Asian countries, could slow cognitive deterioration and ...
BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that BioArctic's co-founder, Professor Lars Lannfelt, was awarded the Lifetime Achievement ...
Eisai said lecanemab was approved in Japan, China, South Korea ... Australia is disappointed that Australians living with Alzheimer’s disease in its early stages may be unable to access the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback